Frankfurt - Delayed Quote EUR
GH Research PLC (1KA.F)
10.70
-0.90
(-7.76%)
At close: June 13 at 9:15:05 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 21.01M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Sale at price 18.12 per share. | Direct | 157,807 | Sep 22, 2020 |
| JENNE KYLE Officer | Sale at price 18.12 per share. | Direct | 13,046 | Sep 22, 2020 |
| PATTERSON JOSHUA F General Counsel | Sale at price 18.12 per share. | Direct | 5,780 | Sep 22, 2020 |
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Stock Award(Grant) at price 18.28 per share. | Direct | 20,181 | Aug 31, 2020 |
| PATTERSON JOSHUA F General Counsel | Sale at price 12.50 per share. | Direct | 3,288 | Jul 17, 2020 |
| ANDREWS WILLIAM T Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 9, 2020 |
| PRICE MICHAEL DENNIS Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 18, 2020 |
| PATTERSON JOSHUA F General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 15, 2020 |
| O'DEA LOUIS Officer | Sale at price 11.75 per share. | Direct | 37,579 | Mar 23, 2020 |
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Sale at price 11.75 per share. | Direct | 110,649 | Mar 23, 2020 |
| JENNE KYLE Officer | Sale at price 11.75 per share. | Direct | 9,153 | Mar 23, 2020 |
| PATTERSON JOSHUA F General Counsel | Sale at price 11.76 per share. | Direct | 3,938 | Mar 23, 2020 |
| O'DEA LOUIS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| JENNE KYLE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| HOWARTH ALEX G Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| PATTERSON JOSHUA F General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2020 |
| MACLEAN MICHAEL F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 15, 2020 |
| O'DEA LOUIS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 15, 2020 |
| HOWARTH ALEX G Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 2, 2019 |
| JENNE KYLE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 21, 2019 |
| SOTEROPOULOS PAULA Chief Executive Officer | Conversion of Exercise of derivative security at price 6.48 - 12.21 per share. | Direct | 14,538,254 | Sep 26, 2019 |
| GOLDBERG JEFF MARC Chief Operating Officer | Conversion of Exercise of derivative security at price 6.48 - 12.21 per share. | Direct | 2,932,747 | Sep 26, 2019 |
| MACLEAN MICHAEL F Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 19, 2019 |
| O'DEA LOUIS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 19, 2019 |
| MCDEVITT DAMIEN PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 19, 2019 |
| BOYCE SARAH President | Sale at price 23.52 per share. | Direct | 42,783 | Jul 15, 2019 |
| BOYCE SARAH President | Stock Award(Grant) at price 20.04 per share. | Direct | 16,295 | Jul 1, 2019 |
| GOLDBERG JEFF MARC Chief Operating Officer | Stock Award(Grant) at price 20.04 per share. | Direct | 8,618 | Jul 1, 2019 |
| SOTEROPOULOS PAULA Chief Executive Officer | Sale at price 32.11 - 32.17 per share. | Direct | 1,020,780 | Apr 8, 2019 |
| SOTEROPOULOS PAULA Chief Executive Officer | Conversion of Exercise of derivative security at price 6.48 per share. | Direct | 205,980 | Apr 8, 2019 |
| GOLDBERG JEFF MARC Chief Operating Officer | Sale at price 31.71 - 31.72 per share. | Direct | 1,585,718 | Apr 8, 2019 |
| GOLDBERG JEFF MARC Chief Operating Officer | Conversion of Exercise of derivative security at price 6.48 per share. | Direct | 324,000 | Apr 8, 2019 |
| SOTEROPOULOS PAULA Chief Executive Officer | Sale at price 32.14 per share. | Direct | 590,856 | Mar 6, 2019 |
| SOTEROPOULOS PAULA Chief Executive Officer | Conversion of Exercise of derivative security at price 6.48 per share. | Direct | 119,141 | Mar 6, 2019 |
Related Tickers
9VC.MU ATAI Life Sciences NV
1.9300
-2.18%
9VC.DE Atai Life Sciences N.V.
1.8545
-2.83%
9VC.F Atai Life Sciences N.V.
1.7920
-1.86%
NEUP Neuphoria Therapeutics Inc.
6.82
-5.40%
AKRO Akero Therapeutics, Inc.
55.62
+3.85%
CYBN Cybin Inc.
8.35
-3.47%
ATAI Atai Life Sciences N.V.
2.1100
-3.21%
EYEN Eyenovia, Inc.
2.4400
-8.61%